[HTML][HTML] Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway …
S Bao, X Wang, Q Ma, C Wei, J Nan, W Ao - Chinese Herbal Medicines, 2022 - Elsevier
Type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD) are the most
problematic metabolic diseases in the world. NAFLD encompasses a spectrum of severity …
problematic metabolic diseases in the world. NAFLD encompasses a spectrum of severity …
[HTML][HTML] The ameliorative effects of saikosaponin in thioacetamide-induced liver injury and non-alcoholic fatty liver disease in mice
GR Chang, WL Lin, TC Lin, HJ Liao, YW Lu - International journal of …, 2021 - mdpi.com
Liver disorders are a major health concern. Saikosaponin-d (SSd) is an effective active
ingredient extracted from Bupleurum falcatum, a traditional Chinese medicinal plant, with …
ingredient extracted from Bupleurum falcatum, a traditional Chinese medicinal plant, with …
Evaluation of various scoring systems as predictors of the need for intensive care unit admission and other adverse outcomes among patients with acute clozapine …
Acute clozapine poisoning (ACP) is frequently reported worldwide. We evaluated the
efficacy of the Poison Severity Score (PSS), Acute Physiology and Chronic Health …
efficacy of the Poison Severity Score (PSS), Acute Physiology and Chronic Health …
[PDF][PDF] The development of the Metabolic-associated Fatty Liver Disease during pharmacotherapy of mental disorders-a review
JK Rogalski, A Subdys… - Current Problems of …, 2022 - sciendo.com
Results: The drugs that can have the greatest impact on the development of MAFLD are
atypical antipsychotics, especially olanzapine, and mood stabilizers (MS)-valproic acid …
atypical antipsychotics, especially olanzapine, and mood stabilizers (MS)-valproic acid …
[HTML][HTML] Curcumin improved glucose intolerance, renal injury, and nonalcoholic fatty liver disease and decreased chromium loss through urine in obese mice
GR Chang, WT Hsieh, LS Chou, CS Lin, CF Wu, JW Lin… - Processes, 2021 - mdpi.com
Obesity-associated hyperglycemia underlies insulin resistance, glucose intolerance, and
related metabolic disorders including type 2 diabetes, renal damage, and nonalcoholic fatty …
related metabolic disorders including type 2 diabetes, renal damage, and nonalcoholic fatty …
Development and validation of a risk prediction nomogram for disposition of acute clozapine intoxicated patients to intensive care unit
Background Clozapine is an atypical antipsychotic drug used for the treatment of refractory
schizophrenia. It is reported as the most toxic in its class. Using serum clozapine level as a …
schizophrenia. It is reported as the most toxic in its class. Using serum clozapine level as a …
[HTML][HTML] Small-interfering RNA targeting proprotein convertase subtilisin/kexin type 9 might promote fatty liver disease and hepatocellular carcinoma through …
FS Fan - Tumor Biology, 2023 - content.iospress.com
Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to low-density lipoprotein (LDL)
receptor and fatty acid translocase CD36, inducing lysosomal degradation of these two …
receptor and fatty acid translocase CD36, inducing lysosomal degradation of these two …
[HTML][HTML] Imipramine accelerates nonalcoholic fatty liver disease, renal impairment, diabetic retinopathy, insulin resistance, and urinary chromium loss in obese mice
GR Chang, PH Hou, CM Wang, JW Lin, WL Lin… - Veterinary …, 2021 - mdpi.com
Imipramine is a tricyclic antidepressant that has been approved for treating depression and
anxiety in patients and animals and that has relatively mild side effects. However, the …
anxiety in patients and animals and that has relatively mild side effects. However, the …
Association between blood chromium and hepatic steatosis assessed by liver ultrasound transient elastography: National Health and Nutrition Examination Survey …
Y Xiang, R Zhou, Z Wang, Y Xue, Y Cao, L Shen… - Frontiers in …, 2024 - frontiersin.org
Background Hepatic steatosis is a significant pathological feature of fatty liver disease (FLD)
which is widely spread with no effective treatment available. Previous studies suggest that …
which is widely spread with no effective treatment available. Previous studies suggest that …
Prevalence and Risk Factors of Non-Alcoholic Fatty Liver Disease (NAFLD) in Non-Obese Patients with Schizophrenia: A Retrospective Study
W Yi, H Wu, W Fu, H Feng, J Huang, H Li… - Diabetes, Metabolic …, 2024 - Taylor & Francis
Background To assess the prevalence and risk factors of NAFLD in non-obese patients with
schizophrenia in a public psychiatric hospital in China. Methods A total of 1,305 adult …
schizophrenia in a public psychiatric hospital in China. Methods A total of 1,305 adult …